KR20080034905A - 쿠프레독신으로 혈관신생을 제어하는 조성물과 방법 - Google Patents

쿠프레독신으로 혈관신생을 제어하는 조성물과 방법 Download PDF

Info

Publication number
KR20080034905A
KR20080034905A KR1020087002477A KR20087002477A KR20080034905A KR 20080034905 A KR20080034905 A KR 20080034905A KR 1020087002477 A KR1020087002477 A KR 1020087002477A KR 20087002477 A KR20087002477 A KR 20087002477A KR 20080034905 A KR20080034905 A KR 20080034905A
Authority
KR
South Korea
Prior art keywords
ala
cupredoxin
gly
val
thr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020087002477A
Other languages
English (en)
Korean (ko)
Inventor
라제스와리 메타
브라드 테일러
토루 야마다
크레이그 베아티에
타파스 다스 구프타
아난다 차카라바티
Original Assignee
더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/244,105 external-priority patent/US7691383B2/en
Priority claimed from US11/436,592 external-priority patent/US7381701B2/en
Application filed by 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 filed Critical 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이
Publication of KR20080034905A publication Critical patent/KR20080034905A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020087002477A 2005-07-19 2006-07-19 쿠프레독신으로 혈관신생을 제어하는 조성물과 방법 Ceased KR20080034905A (ko)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US70029705P 2005-07-19 2005-07-19
US60/700,297 2005-07-19
US11/244,105 US7691383B2 (en) 2004-10-07 2005-10-06 Cupredoxin derived transport agents and methods of use thereof
US11/244,105 2005-10-06
US76474906P 2006-02-03 2006-02-03
US60/764,749 2006-02-03
US11/436,592 2006-05-19
US11/436,592 US7381701B2 (en) 2001-02-15 2006-05-19 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins

Publications (1)

Publication Number Publication Date
KR20080034905A true KR20080034905A (ko) 2008-04-22

Family

ID=37772089

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087002477A Ceased KR20080034905A (ko) 2005-07-19 2006-07-19 쿠프레독신으로 혈관신생을 제어하는 조성물과 방법

Country Status (10)

Country Link
EP (1) EP1904081A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009502797A (cg-RX-API-DMAC7.html)
KR (1) KR20080034905A (cg-RX-API-DMAC7.html)
AU (1) AU2006284490A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0615555A2 (cg-RX-API-DMAC7.html)
CA (1) CA2615560A1 (cg-RX-API-DMAC7.html)
IL (1) IL188691A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008000993A (cg-RX-API-DMAC7.html)
NO (1) NO20080829L (cg-RX-API-DMAC7.html)
WO (1) WO2007024368A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158574B2 (en) * 2004-10-07 2012-04-17 Cdg Therapeutics, Inc. Compositions and methods to prevent cancer with cupredoxins
EP2061498A4 (en) * 2006-09-14 2009-11-04 Univ Illinois COMPOSITIONS AND METHOD FOR CANCER PREPARATION WITH CUPREDOXINES
AU2007329375A1 (en) 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7491394B2 (en) * 2001-02-15 2009-02-17 The Board Of Trustees Of The University Of Illinois Cytotoxic factors for modulating cell death
UA97466C2 (ru) * 2004-10-07 2012-02-27 Ананда Чакрабарти Транспортирующие соединения - производные купредоксина и способы их применения
AU2006277009A1 (en) * 2005-05-20 2007-02-15 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
JP2008545398A (ja) * 2005-05-20 2008-12-18 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ キュプレドキシンおよびシトクロムcを用いてhiv感染を治療するための組成物および方法
AU2006251742A1 (en) * 2005-05-20 2006-11-30 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating malaria with cupredoxin and cytochrome

Also Published As

Publication number Publication date
WO2007024368A3 (en) 2007-10-11
WO2007024368A2 (en) 2007-03-01
IL188691A0 (en) 2008-08-07
AU2006284490A8 (en) 2008-02-28
NO20080829L (no) 2008-04-02
EP1904081A4 (en) 2008-12-03
EP1904081A2 (en) 2008-04-02
CA2615560A1 (en) 2007-03-01
AU2006284490A1 (en) 2007-03-01
BRPI0615555A2 (pt) 2009-07-14
MX2008000993A (es) 2008-03-19
JP2009502797A (ja) 2009-01-29

Similar Documents

Publication Publication Date Title
US9107881B2 (en) Compositions and methods to control angiogenesis with cupredoxins
EP1653990B1 (en) Use of polypeptides of the cupredoxin family in cancer therapy
US7338766B2 (en) Compositions and methods for treating malaria with cupredoxin and cytochrome
KR20090114414A (ko) 쿠프레독신으로 암을 예방하는 조성물과 방법
CN101600447A (zh) 铜氧还蛋白衍生肽类的修饰物及其使用方法
SG174784A1 (en) Compositions and methods to prevent cancer with cupredoxins
US10117905B2 (en) Compositions and methods to prevent cancer with cupredoxins
KR20080040631A (ko) 에프린 신호전달과 관련된 질환을 쿠프레독신으로 치료하기위한 조성물과 방법
KR20110120275A (ko) 큐프레독신으로 암을 예방하기 위한 조성물 및 방법
MX2008000993A (es) Composiciones y metodos para controlar la angiogenesis con cupredoxinas.
CN101272800A (zh) 使用铜氧还蛋白控制血管发生的组合物和方法
KR20080019615A (ko) 쿠프레독신과 시토크롬으로 말라리아를 치료하기 위한조성물과 방법
KR20080024124A (ko) 쿠프레독신과 시토크롬 c로 hiv 감염을 치료하기 위한조성물과 방법
ZA200602126B (en) Use of polypeptides of the cupredoxin family in cancer therapy
CN101198351A (zh) 用铜氧还蛋白治疗ephrin信号传导相关性病变的组合物和方法
MXPA06001820A (en) Use of polypeptides of the cupredoxin family in cancer therapy

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20080130

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20110715

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130419

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20131030

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20130419

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I